Register entry

Soleno Therapeutics, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
3
Live patents
18
Exclusivities
1
Countries
0
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.

Dosage formNDCs
tablet, film coated3
RouteNDCs
oral3
Labeller name on the listingNDCs
soleno therapeutics, inc.3
Exclusivity

Patents and exclusivities

18
PatentProductCoversExpiry
7572789VYKAT XRdiazoxide cholinesubstance, productDec 2026
7799777VYKAT XRdiazoxide cholinesubstanceMar 2029
12178823VYKAT XRdiazoxide cholineuseNov 2035
12343348VYKAT XRdiazoxide cholineuseNov 2035
12419895VYKAT XRdiazoxide cholineuseNov 2035
9757384VYKAT XRdiazoxide cholineuseNov 2035
ProductExclusivityUntil
VYKAT XRDIAZOXIDE CHOLINEODE-532 Orphan drugMar 2032
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
VYKAT XRdiazoxide cholinetablet, film coated, oral83860-025NDA
VYKAT XRdiazoxide cholinetablet, film coated, oral83860-075NDA
VYKAT XRdiazoxide cholinetablet, film coated, oral83860-150NDA
Enquiry

Common questions

Is Soleno Therapeutics, Inc. FDA approved?
Soleno Therapeutics, Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Soleno Therapeutics, Inc. make?
3 products are listed under Soleno Therapeutics, Inc. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.